ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 94 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,400,020 | +3.1% | 898,000 | 0.0% | 0.33% | +9.6% |
Q2 2023 | $17,843,260 | +16.0% | 898,000 | 0.0% | 0.30% | +7.1% |
Q1 2023 | $15,382,740 | +67.0% | 898,000 | +90.8% | 0.28% | +54.9% |
Q4 2022 | $9,210,699 | -74.0% | 470,654 | -69.6% | 0.18% | -73.8% |
Q3 2020 | $35,433,000 | +9.2% | 1,550,000 | 0.0% | 0.69% | -1.6% |
Q2 2020 | $32,442,000 | +64.4% | 1,550,000 | +9.5% | 0.70% | +10.3% |
Q1 2020 | $19,739,000 | -38.7% | 1,415,000 | 0.0% | 0.64% | -29.5% |
Q4 2019 | $32,205,000 | +95.4% | 1,415,000 | 0.0% | 0.91% | +66.4% |
Q3 2019 | $16,485,000 | +10.5% | 1,415,000 | +42.3% | 0.54% | +20.3% |
Q2 2019 | $14,915,000 | +20.0% | 994,314 | +40.3% | 0.45% | +5.8% |
Q1 2019 | $12,429,000 | +18.4% | 708,600 | 0.0% | 0.43% | -8.0% |
Q4 2018 | $10,501,000 | +8.1% | 708,600 | +79.6% | 0.46% | +30.3% |
Q3 2018 | $9,715,000 | +25.4% | 394,585 | 0.0% | 0.36% | +11.2% |
Q2 2018 | $7,746,000 | +4.7% | 394,585 | 0.0% | 0.32% | -7.2% |
Q1 2018 | $7,398,000 | – | 394,585 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |